We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
56 hedge funds and large institutions have $63.8M invested in Lineage Cell Therapeutics in 2013 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
178% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.84% less ownership
Funds ownership: 36.82% → 35.98% (-0.84%)
3% less capital invested
Capital invested by funds: $65.6M → $63.8M (-$1.78M)
3% less funds holding
Funds holding: 58 → 56 (-2)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
69% less call options, than puts
Call options by funds: $202K | Put options by funds: $654K
Holders
56
Holders Change
-2
Holders Change %
-3.45%
% of All Funds
1.82%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
25
Reduced
9
Closed
6
Calls
$202K
Puts
$654K
Net Calls
-$452K
Net Calls Change
+$127K
